valganciclovir - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/25738669/ Valganciclovir for symptomatic congenital cytomegalovirus disease Treating symptomatic congenital CMV disease with valganciclovir for 6 months, as compared with 6 weeks, did not improve hearing in the short term but appeared... valganciclovir symptomatic congenital cytomegalovirus disease https://adisinsight.springer.com/drugsafety/803658911?error=cookies_not_supported&code=33ef7abd-ce06-4921-8451-695ba39b4068 Valganciclovir - AdisInsight A 64-year-old woman exhibited lack of efficacy while receiving valganciclovir for cytomegalovirus (CMV) viraemia.The woman, who had COPD, underwent bilateral valganciclovir adisinsight https://adisinsight.springer.com/drugsafety/803464349?error=cookies_not_supported&code=ed4c54ac-f297-4397-8f12-7dbf2bc63679 Valganciclovir - AdisInsight In a retrospective study of 83 children conducted during 2010 to 2015, a child [age and sex not stated] was described, who developed grade 2 tremor following valganciclovir adisinsight https://adisinsight.springer.com/drugsafety/803495748?error=cookies_not_supported&code=56cde1bd-522e-4669-941e-9d77d98db770 Ganciclovir/valganciclovir - AdisInsight In a study of 59 infants conducted between January 2015 to December 2019, an 8-month-old boy and an approximately 6-month-old girl were described, who developed ganciclovir adisinsight https://pubchem.ncbi.nlm.nih.gov/patent/US-2014179719-A1 Novel amorphous solid dispersions of valganciclovir hydrochloride - Patent US-2014179719-A1 -... US-2014179719-A1 chemical patent summary. valganciclovir hydrochloride patent us novel amorphous solid https://www.ti.ubc.ca/2010/06/28/ganciclovir-and-valganciclovir-preemptive-treatment-cmv-adult-patients-who-have-undergone-allogeneic/ Therapeutics Initiative | Ganciclovir and valganciclovir for the preemptive treatment of CMV in... for the https://hsrc.himmelfarb.gwu.edu/gwhpubs/2363/ "Optimizing ganciclovir and valganciclovir dosing regimens in pediatric" by Qiu-Yue Li, John van... INTRODUCTION: Infants and immunocompromised children with cytomegalovirus (CMV) infection have significant morbidity and mortality. Ganciclovir (GCV) and its... https://adisinsight.springer.com/trials/700267295?error=cookies_not_supported&code=f90c1691-5ed1-4958-a921-4aa270d158de A study to evaluate the oral valganciclovir as preemptive therapy for cytomegalovirus reactivation... The purpose of this study is to analyze valganciclovir as preemptive therapy for cytomegalovirus reactivation is safe and effective in pediatric hematopoietic